Please provide your email address to receive an email when new articles are posted on . In adults with peripheral arterial disease, a directional atherectomy system significantly reduced vessel ...

Please provide your email address to receive an email when new articles are posted on . Medtronic is recalling its HawkOne Directional Atherectomy System due to risk for the tip of the catheter ...

FRANKLIN LAKES, N.J., May 28, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to initiate a patient data ...

AngioDynamics, Inc. ANGO recently launched the Auryon Atherectomy System, a newly developed path-breaking technology for the treatment of Peripheral Artery Disease (“PAD”), which includes Critical ...

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, ...

For patients with peripheral arterial disease, the mainstay of initial treatment is always risk factor modification, ambulation, and compliance with guideline-based medical therapies. However, for ...

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, ...

Dr. Aaron Kovaleski, a renowned expert in endovascular interventions, has conducted research on the use of the Auryon atherectomy system for PAD interventions. Peripheral artery disease is a common ...

Medtronic has recalled 686 TurboHawk Plus Directional Atherectomy Systems because there is a risk that the guidewire within the catheter may move downward or prolapse during use, which may damage the ...

Medtronic has recalled 95,110 HawkOne Directional Atherectomy Systems because of the risk of the guidewire within the catheter moving downward or prolapsing during use, which may damage the tip of the ...